Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term aspirin desensitization therapy for prevention of recurrent nasal polyposis in aspirin-intolerant patients
2005-004437-18Phase 2Completed
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- May 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) and aspirin-exacerbated respiratory disease (AERD) comparing Acetylsalicylic acid desensitization therapy with Placebo (2 arms). Primary endpoint: Rate of recurrence of nasal polyposis/chronic rhinosinusitis after 3 years of acetylsalicylic acid desensitization therapy. Started May 2006; status: completed.
02
Drugs
aspirin
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)aspirin-exacerbated respiratory disease (AERD)
Beyond the preview
Go deeper on 2005-004437-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004437-18.